Literature DB >> 33857386

Pilot Analyses of Interferon Subtype Expression Profiles in Patients with Herpes Zoster or Postherpetic Neuralgia.

Yu-Chih Chen1, Robert W Figliozzi1, Shaochung V Hsia1.   

Abstract

Postherpetic neuralgia (PHN) is a painful neuropathic complication resulting from herpes zoster (HZ). The pain manifests in peripheral nerves infected by herpesviruses, mostly from reactivation of latent varicella zoster virus. Mechanistic descriptions suggest that PHN develops because of disrupted immune system signaling and inflammation or peripheral nerve damage; however, the pathophysiology is not clear. It is difficult to predict/prevent PHN manifestations of HZ patients due to the lack of accurate diagnostics. In this study, sera from healthy controls, HZ patients, and PHN patients were subjected to an interferon (IFN) expression profile (IEP) study. The corresponding cDNAs were analyzed by quantitative reverse transcription-polymerase chain reaction (qRT-PCR) using primer pairs against a panel of 21 different IFN subtypes. The results showed that distinct IEPs were observed among HZ and PHN cohorts in comparison to the healthy controls. Together, this pilot study suggested that the IEP study may be used as a molecular tool for diagnosis of PHN and assist in designing new PHN therapeutic protocols.

Entities:  

Keywords:  Postherpetic Neuralgia; diagnoses; herpes zoster; interferons

Mesh:

Substances:

Year:  2021        PMID: 33857386      PMCID: PMC8563454          DOI: 10.1089/vim.2020.0295

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.175


  25 in total

Review 1.  Interferon activation and innate immunity.

Authors:  C Le Page; P Génin; M G Baines; J Hiscott
Journal:  Rev Immunogenet       Date:  2000

2.  Presentation and management of herpes zoster (shingles) in the geriatric population.

Authors:  Kenneth R Cohen; Rebecca L Salbu; Jerry Frank; Igor Israel
Journal:  P T       Date:  2013-04

Review 3.  Clinical practice. Postherpetic neuralgia.

Authors:  Robert W Johnson; Andrew S C Rice
Journal:  N Engl J Med       Date:  2014-10-16       Impact factor: 91.245

4.  The impact of pain intensity on quality of life of postherpetic neuralgia patients.

Authors:  Wizar Putri Mellaratna; Nelva K Jusuf; Ariyati Yosi
Journal:  Med Glas (Zenica)       Date:  2020-08-01

Review 5.  The varicella vaccine. Clinical trials in immunocompromised individuals.

Authors:  A A Gershon; P LaRussa; S Steinberg
Journal:  Infect Dis Clin North Am       Date:  1996-09       Impact factor: 5.982

6.  Thyroid hormone-dependent epigenetic suppression of herpes simplex virus-1 gene expression and viral replication in differentiated neuroendocrine cells.

Authors:  Robert W Figliozzi; Feng Chen; Matthew Balish; Amakoe Ajavon; S Victor Hsia
Journal:  J Neurol Sci       Date:  2014-08-20       Impact factor: 3.181

Review 7.  Interferons, interferon-like cytokines, and their receptors.

Authors:  Sidney Pestka; Christopher D Krause; Mark R Walter
Journal:  Immunol Rev       Date:  2004-12       Impact factor: 12.988

8.  The differential activity of interferon-α subtypes is consistent among distinct target genes and cell types.

Authors:  Herwig P Moll; Thomas Maier; Anna Zommer; Thomas Lavoie; Christine Brostjan
Journal:  Cytokine       Date:  2010-10-12       Impact factor: 3.861

Review 9.  Postherpetic neuralgia: epidemiology, pathophysiology, and pain management pharmacology.

Authors:  Theresa Mallick-Searle; Brett Snodgrass; Jeannine M Brant
Journal:  J Multidiscip Healthc       Date:  2016-09-21

10.  Altered gray matter volume in patients with herpes zoster and postherpetic neuralgia.

Authors:  Jiaqi Liu; Lili Gu; Qing Huang; Shunda Hong; Xianjun Zeng; Daying Zhang; Fuqing Zhou; Jian Jiang
Journal:  J Pain Res       Date:  2019-02-07       Impact factor: 3.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.